Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S on Valueinvesting subreddit by Menu-Quirky. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S's share was trading at $50.03 as of July 30^th. NVO’s trailing and forward P/E were 13.71 and 12.39, respectively according to Yahoo Finance.

[caption id="attachment_1238439" align="aligncenter" width="768"] A pharmacist holding a box of Exenatide, used to treat type 2 diabetes.[/caption]

Novo Nordisk presents a compelling case of a high-quality growth company temporarily priced like a value stock. Following...